This distinction in mutation types provides a clearer understanding of the genetic basis for CPVT and informs genetic counseling and diagnostic strategies (11), CASQ2 variants account for 2%–5% of all CPVT cases (12). The gene discussed is CASQ2; the disease is catecholaminergic polymorphic ventricular tachycardia.